Obagi Medical Products to Present at 26th Annual JPMorgan Healthcare Conference

Business Wire, Dec 26, 2007

LONG BEACH, Calif. -- Obagi Medical Products, Inc. (NASDAQ:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that Company management will present a corporate overview at the 26th Annual JPMorgan Healthcare Conference, to be held on January 7 - 10, 2008, at the Westin St. Francis in San Francisco, Calif.

Obagi's presentation will take place at 12:30 p.m. (PT) on Thursday, January 10, 2008. A live webcast of the presentations will be available via the Internet by visiting the investor relations section of the Company's Web site at www.obagi.com. An archived presentation will be available on the web site for 30 days.

About Obagi Medical Products, Inc.

Obagi Medical Products develops and commercializes skin health products for the dermatology, plastic surgery, and related aesthetic markets. Using its Penetrating Therapeutics[TM] technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including chloasma, melasma, senile lentigines, acne vulgaris and sun damage. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm, 1988; Obagi-C Rx (the first and only prescription-strength vitamin C and hydroquinone system), 2004; Obagi Professional-C (a line of highly stable vitamin C serums), 2005; Obagi Nu-Derm Condition and Enhance for use with cosmetic procedures to enhance patient outcomes and satisfaction, 2006; Obagi ELASTIderm eye skin care and Obagi CLENZIderm M.D. acne therapeutic systems 2007; and a formulation of CLENZIderm for normal to dry skin in July 2007. Obagi's products are only available through physicians. Visit www.obagi.com for information.